Rolinsatamab provides a monoclonal antibody platform for cancer and antibody research and specifically supports studies of antigen recognition, antibody-mediated cellular targeting, and antibody characterization. Researchers can use it to investigate target engagement and cellular responses in experimental models expressing its intended antigen.
Key Features and Benefits
- Monoclonal Antibody Platform: Provides an antibody specifically for investigating antigen recognition and antibody-mediated biological activity.
- Target Recognition: Supports evaluation of antibody interactions with its designated molecular target.
- Antibody Binding Research: Enables investigation of antigen binding, specificity, and target engagement.
- Cancer Research Applications: Supports antibody-based studies in relevant tumor cell models.
- Cellular Response Studies: Useful for examining cellular responses specifically associated with antibody-target interactions.
- Antibody Characterization: Supports evaluation of antibody binding properties, stability, and functional activity.
- Antibody Engineering Research: Provides a platform specifically for investigating antibody modification and potential conjugation strategies.
Applications
- Oncology Research: Supports investigation of antibody-mediated targeting in appropriate cancer models.
- Monoclonal Antibody Research: Useful for studying antigen recognition and antibody-target interactions.
- Target Engagement Assays: Supports evaluation of antibody binding to its intended molecular target.
- Cell-Based Assays: Useful for investigating antibody interactions and cellular responses.
- Antibody Characterization: Enables studies of binding specificity, stability, and functional properties.
- Antibody Engineering: Supports investigation of antibody modification and conjugation approaches.
- Comparative Antibody Research: Especially useful for comparing antigen recognition and binding characteristics across antibody candidates.
Storage and Handling
- Storage: Store according to the product specification under recommended temperature conditions. Protect from excessive heat and repeated freeze-thaw cycles.
- Handling: Handle using appropriate procedures for monoclonal antibody research materials. Maintain conditions that preserve antibody stability, structural integrity, and antigen-binding activity.
Rolinsatamab provides a monoclonal antibody platform for investigating antigen recognition and antibody-mediated cellular interactions and specifically supports oncology research, antibody characterization, target engagement, and cell-based assays.
AxisPharm offers 5000+ PEG Linkers with high purity. Different kinds of PEG Reagents may be available by custom synthesis.
